François Rouet

François Rouet

Auto-generated profile, based on publicly available information

François Rouet

Virology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Journal of Clinical Virology
Verified
Journal Article
Closed access
OSOlivier Ségéral
Olivier Ségéral
DNDieynaba S. N’dIaye
Dieynaba S. N’dIaye
SPSophearot Prak
Sophearot Prak
JNJanin Nouhin
Janin Nouhin
SCSamsorphea Chhun
Samsorphea Chhun
FRFrançois Rouet
François Rouet

24 January 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FRFrançois Rouet
François Rouet
LDLuc Deleplancque
Luc Deleplancque
BMBerthold Bivigou Mboumba
Berthold Bivigou Mboumba
JSJeanne Sica
Jeanne Sica
AMAugustin Mouinga-Ondémé
Augustin Mouinga-Ondémé
CGCatherine Gaudy-Graffin
Catherine Gaudy-Graffin
Guidelines for optimized HCV screening are urgently required in Africa, especially for patients infected with HIV, who sometimes show false positive or false negative reactivity in anti-HCV antibody assays. Here, we assessed the usefulness of a fourth-generation HCV Ag-Ab ELISA for the identification of active HCV infection in HIV-positive patients. This cross-sectional study was conducted between 03/2010 and 01/2013 and included 762 Gabonese HIV-positive adult patients. The results of ELISA (Monolisa HCV Ag-Ab ULTRA, Bio-Rad) were compared with those obtained by RT-PCR (gold standard). The optimal ELISA signal-to-cutoff (S/CO) ratio to identify patients with active hepatitis C (positive HCV RNA) was determined. Specimens were further tested by the INNO-LIA HCV Score assay (Innogenetics) and the Architect HCV Ag kit (Abbott) to define the best diagnostic strategy. Sixty-seven patients tested positive for HCV (S/CO ratio ≥ 1) by ELISA. Of these, 47 (70.1%) tested positive for HCV RNA. The optimal S/CO associated with active HCV infection was 1.7. At this threshold, the sensitivity of ELISA was 97.9% (95% confidence interval (CI) 90.0–99.9%), its specificity was 91.3% (95% CI 85.0–95.5%), and HCV seroprevalence rate was 7.3% (56/762) (95% CI 5.6–9.4%). Among 57 HCV-seropositive patients with available INNO-LIA results, false reactivity was identified in 14 (24.6%), resolved HCV infection in two (3.5%), possible acute HCV infections in nine (15.8%) and likely chronic HCV infections in 32 (56.1%) patients. HCV core Ag was undetectable in 14/15 (93.3%) specimens that tested negative for HCV RNA whereas it was quantified in 34 (out of 39, 87.2%) samples that tested positive for HCV RNA. Our study provides comprehensive guidance for HCV testing in Gabon, and will help greatly clinicians to improve case definitions for both the notification and surveillance of HCV in patients co-infected with HIV.

1 November 2007 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
FRFrançois Rouet
François Rouet
CRChristine Rouzioux
Christine Rouzioux

2 August 2016 in Transfusion
Verified
Journal Article
Closed access
PDF file
JNJanin Nouhin
Janin Nouhin
SPSophearot Prak
Sophearot Prak
YMYoann Madec
Yoann Madec
HBHubert Barennes
Hubert Barennes
RWRichard Weissel
Richard Weissel
FRFrançois Rouet
François Rouet

1 October 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
JNJanin Nouhin
Janin Nouhin
HBHubert Barennes
Hubert Barennes
YMYoann Madec
Yoann Madec
SPSophearot Prak
Sophearot Prak
SHSerey Vannak Hou
Serey Vannak Hou
FRFrançois Rouet
François Rouet

22 July 2014 in Viruses
Verified
Journal Article
Open access
PDF file
Florian LiegeoisFlorian Liegeois
Florian Liegeois
FSFabian Schmidt
Fabian Schmidt
VBVanina Boué
Vanina Boué
CBChristelle Butel
Christelle Butel
FMFatima Mouacha
Fatima Mouacha
FRFrançois Rouet
François Rouet
The Simian Immunodeficiency Virus (SIV) mus/mon/gsn lineage is a descendant of one of the precursor viruses to the HIV-1/SIVcpz/gor viral lineage. SIVmus and SIVgsn were sequenced from mustached and greater spot nosed monkeys in Cameroon and SIVmon from mona monkeys in Cameroon and Nigeria. In order to further document the genetic diversity of SIVmus, we analyzed two full-length genomes of new strains identified in Gabon. The whole genomes obtained showed the expected reading frames for gag, pol, vif, vpr, tat, rev, env, nef, and also for a vpu gene. Analyses showed that the Gabonese SIVmus strains were closely related and formed a monophyletic clade within the SIVmus/mon/gsn lineage. Nonetheless, within this lineage, the position of both new SIVmus differed according to the gene analyzed. In pol and nef gene, phylogenetic topologies suggested different evolutions for each of the two new SIVmus strains whereas in the other nucleic fragments studied, their positions fluctuated between SIVmon, SIVmus-1, and SIVgsn. In addition, in C1 domain of env, we identified an insertion of seven amino acids characteristic for the SIVmus/mon/gsn and HIV‑1/SIVcpz/SIVgor lineages. Our results show a high genetic diversity of SIVmus in mustached monkeys and suggest cross-species transmission events and recombination within SIVmus/mon/gsn lineage. Additionally, in Central Africa, hunters continue to be exposed to these simian viruses, and this represents a potential threat to humans.